# TScan Therapeutics, Inc.: filings

TCRX · Nasdaq · CIK 1783328 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tcrx.md) · [Financials](/companies/tcrx/financials.md) · [Filings](/companies/tcrx/filings.md) · [Insiders](/companies/tcrx/insiders.md)

## Reports and events: 102 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 97, 8-K 65, 3 22, 10-Q 16, CORRESP 13, SC 13G 13, SC 13G/A 11, SCHEDULE 13G/A 10, S-8 8, UPLOAD 8, 424B5 6, DEF 14A 6, 10-K 5, DEFA14A 5, EFFECT 5, ARS 4, S-1/A 4, S-3 4, FWP 3, S-3/A 3, SC 13D/A 3, SEC STAFF LETTER 3, 144 2, D 2, PRE 14A 2, 10-K/A 1, 424B4 1, 8-A12B 1, AW 1, CERT 1, DRS 1, S-1 1, S-1MEF 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 08:07 ET | [DEF 14A](/filings/0001193125-26-431045.md) | Proxy statement, period 2026-11-20 | 0001193125-26-431045 |
| 2026-10-16 | 16:45 ET | [8-K](/filings/0001193125-26-424198.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-424198 |
| 2026-09-30 | 17:00 ET | [8-K](/filings/0001193125-26-409199.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-409199 |
| 2026-09-11 | 08:00 ET | [8-K](/filings/0001193125-26-388631.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-388631 |
| 2026-09-02 | 07:22 ET | [8-K](/filings/0001193125-26-379343.md) | 2.05 Exit or disposal costs; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-379343 |
| 2026-08-18 | 17:00 ET | [8-K](/filings/0001193125-26-355664.md) | 1.02 Termination of a material agreement | 0001193125-26-355664 |
| 2026-08-12 | 07:30 ET | [10-Q](/filings/0001193125-26-345749.md) | Quarterly report, period 2026-06-30 | 0001193125-26-345749 |
| 2026-08-12 | 07:15 ET | [8-K](/filings/0001193125-26-345732.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-345732 |
| 2026-06-22 | 07:09 ET | [8-K](/filings/0001193125-26-276693.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276693 |
| 2026-05-22 | 16:05 ET | [8-K](/filings/0001193125-26-236862.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-236862 |
| 2026-05-06 | 07:30 ET | [10-Q](/filings/0001193125-26-207572.md) | Quarterly report, period 2026-03-31 | 0001193125-26-207572 |
| 2026-05-06 | 07:15 ET | [8-K](/filings/0001193125-26-207549.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-207549 |
| 2026-04-17 | 07:30 ET | [DEF 14A](/filings/0001193125-26-160304.md) | Proxy statement, period 2026-05-20 | 0001193125-26-160304 |
| 2026-04-02 | 07:30 ET | [8-K](/filings/0001193125-26-138973.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-138973 |
| 2026-03-04 | 07:30 ET | [10-K](/filings/0001193125-26-089884.md) | Annual report, period 2025-12-31 | 0001193125-26-089884 |
| 2026-03-04 | 07:15 ET | [8-K](/filings/0001193125-26-089871.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-089871 |
| 2026-01-12 | 07:30 ET | [8-K](/filings/0001193125-26-009771.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009771 |
| 2025-11-26 | 16:15 ET | [8-K](/filings/0001193125-25-300538.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-300538 |
| 2025-11-12 | 07:30 ET | [10-Q](/filings/0001193125-25-275933.md) | Quarterly report, period 2025-09-30 | 0001193125-25-275933 |
| 2025-11-12 | 07:15 ET | [8-K](/filings/0001193125-25-275889.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-275889 |
| 2025-11-03 | 06:35 ET | [8-K](/filings/0001193125-25-261612.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-261612 |
| 2025-09-09 | 07:00 ET | [8-K](/filings/0001193125-25-198768.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-198768 |
| 2025-08-20 | 16:10 ET | [8-K](/filings/0001193125-25-184083.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-184083 |
| 2025-08-12 | 07:30 ET | [10-Q](/filings/0000950170-25-106919.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106919 |
| 2025-08-12 | 07:15 ET | [8-K](/filings/0000950170-25-106915.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106915 |
| 2025-07-02 | 07:00 ET | [8-K](/filings/0001193125-25-154336.md) | 5.07 Shareholder vote results | 0001193125-25-154336 |
| 2025-05-14 | 07:01 ET | [DEF 14A](/filings/0001193125-25-119378.md) | Proxy statement, period 2025-06-30 | 0001193125-25-119378 |
| 2025-05-06 | 07:30 ET | [10-Q](/filings/0000950170-25-063968.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063968 |
| 2025-05-06 | 07:15 ET | [8-K](/filings/0000950170-25-063959.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063959 |
| 2025-03-05 | 07:30 ET | [10-K](/filings/0000950170-25-033077.md) | Annual report, period 2024-12-31 | 0000950170-25-033077 |
| 2025-03-05 | 07:15 ET | [8-K](/filings/0000950170-25-033071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-033071 |
| 2024-12-26 | 07:30 ET | [8-K](/filings/0001193125-24-284671.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-284671 |
| 2024-12-23 | 07:27 ET | [8-K](/filings/0001193125-24-283673.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-283673 |
| 2024-12-10 | 08:14 ET | [8-K](/filings/0001193125-24-273985.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-273985 |
| 2024-11-21 | 08:05 ET | [8-K](/filings/0000950142-24-002817.md) | 3.02 Unregistered sale of equity | 0000950142-24-002817 |
| 2024-11-12 | 07:30 ET | [10-Q](/filings/0000950170-24-124575.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124575 |
| 2024-11-12 | 07:15 ET | [8-K](/filings/0000950170-24-124558.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124558 |
| 2024-11-01 | 07:00 ET | [8-K](/filings/0001193125-24-249124.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-249124 |
| 2024-08-12 | 07:30 ET | [10-Q](/filings/0000950170-24-095066.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095066 |
| 2024-08-12 | 07:15 ET | [8-K](/filings/0000950170-24-095063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095063 |
| 2024-06-14 | 07:15 ET | [8-K](/filings/0001193125-24-161151.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-161151 |
| 2024-05-13 | 07:30 ET | [10-Q](/filings/0000950170-24-058198.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058198 |
| 2024-05-13 | 07:15 ET | [8-K](/filings/0000950170-24-058194.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-058194 |
| 2024-04-30 | 16:07 ET | [DEF 14A](/filings/0001193125-24-125066.md) | Proxy statement, period 2024-06-12 | 0001193125-24-125066 |
| 2024-04-23 | 16:25 ET | [SC 13D/A](/filings/0001104659-24-050607.md) | Ownership report, active investor, amended | 0001104659-24-050607 |
| 2024-04-17 | 06:25 ET | [8-K](/filings/0001193125-24-098509.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-098509 |
| 2024-04-16 | 16:16 ET | [8-K](/filings/0001193125-24-097764.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-097764 |
| 2024-04-10 | 07:30 ET | [10-K/A](/filings/0001193125-24-091386.md) | Annual report, amended, period 2023-12-31 | 0001193125-24-091386 |
| 2024-04-08 | 08:17 ET | [8-K](/filings/0001193125-24-089164.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-089164 |
| 2024-03-06 | 07:30 ET | [10-K](/filings/0000950170-24-026875.md) | Annual report, period 2023-12-31 | 0000950170-24-026875 |

Page 1 of 3. [Older](/companies/tcrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 08:08 ET. No prices; not investment advice.